📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens. (2021)

First Author: Sawant N

Attributed to: The Future Vaccine Manufacturing Research Hub (Vax-Hub) funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.xphs.2020.11.039

PubMed Identifier: 33285182

Publication URI: http://europepmc.org/abstract/MED/33285182

Type: Journal Article/Review

Volume: 110

Parent Publication: Journal of pharmaceutical sciences

Issue: 3

ISSN: 0022-3549